Recent evidence demonstrated that small molecule inhibition of EZH2 significantly reduced growth of germinal center-derived DLBCL cells, and conditional expression of an EZH2 mutant lymphoma allele was shown to drive lymphomagenesis [52]. This evidence concerns the gene EZH2 and diffuse large B-cell lymphoma.